Compare

    Two terms, side by side

    Pick any two terms to see definitions, context, pitfalls, and sources in parallel.

    Curated comparison tables

    In-depth, attribute-by-attribute tables for the most common MedTech term pairs. Each row is sourced from the linked term pages.

    Reimbursement

    Outpatient Prospective Payment System(OPPS)

    In one line
    Medicare's payment system for hospital outpatient services.
    Definition
    OPPS pays hospital outpatient departments via Ambulatory Payment Classifications (APCs) - bundled payment groups for outpatient procedures. ASCs are paid under a parallel ASC payment system tied to OPPS. CMS updates OPPS each year through a proposed rule in the summer and a final rule effective January 1. APCs group services that are clinically and financially similar, and comprehensive APCs bundle related services into one payment. The rule also sets device-intensive status, which affects how payment changes when procedures move to ASCs.
    Why it matters
    Annual OPPS rule sets APC weights, device pass-throughs, and ASC-payable procedure list - a major commercial determinant for outpatient devices.
    Common pitfalls
    • •A common pitfall is misunderstanding the impact of APCs on device reimbursement, assuming direct payment for devices rather than bundled payments for procedures. Another mistake is failing to monitor the annual OPPS rule changes, which can significantly affect market access and pricing strategies for outpatient MedTech. Companies sometimes overlook the distinct but parallel payment system for Ambulatory Surgical Centers (ASCs), leading to incomplete reimbursement strategies.
    • •It is crucial to differentiate between an outpatient service being covered by Medicare and the specific payment methodology under OPPS, as not all covered services are reimbursed via APCs.
    • •Some MedTech manufacturers incorrectly assume that device pass-through status is permanent, rather than a temporary payment mechanism subject to specific criteria and time limits.
    • •Misinterpreting the APC assignment for a new device, or assuming a specific APC will apply without understanding the clinical and cost data CMS uses for classification, can lead to inaccurate financial projections.
    Open full page
    Select term B to compare.

    Why compare MedTech terms side by side?

    MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

    Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

    Common comparison patterns

    How to use this tool

    Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

    MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.